Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-01 | Mr. Mark A. MoraisCOO & President of Clinical Services | -4,87k | 75,37k | Derivative Exercise and Sale | 15,49 | 80,66k | - |
| 2026-06-01 | Mr. Mark A. MoraisCOO & President of Clinical Services | 6,14k | 0,00 | Derivative Exercise and Retained Stock | - | 80,66k | 8,24% |
| 2026-06-01 | Ms. Jill McConnellCFO | -4,87k | 75,37k | Derivative Exercise and Sale | 15,49 | 78,42k | - |
| 2026-06-01 | Ms. Jill McConnellCFO | 6,14k | 0,00 | Derivative Exercise and Retained Stock | - | 78,42k | 8,50% |
| 2026-05-18 | Mr. Robert ParksCAO | -2,00k | 26,88k | Verkauf | 13,44 | 20,39k | -8,93% |
| 2026-05-14 | Mr. Peter M. NeupertChairman of the Board & Lead Independent Director | 148,54k | 0,00 | Derivative Exercise and Retained Stock | - | 246,67k | 151,36% |
| 2026-03-20 | Ms. Erin L. RussellIndependent Director | 23,95k | 0,00 | Derivative Exercise and Retained Stock | - | 33,80k | 243,01% |
| 2026-03-13 | Mr. Mark A. MoraisCOO & President of Clinical Services | 2,48k | 0,00 | Derivative Exercise and Retained Stock | - | 74,52k | 3,44% |
| 2026-03-13 | Mr. Mark A. MoraisCOO & President of Clinical Services | -1,80k | 16,63k | Derivative Exercise and Sale | 9,22 | 74,52k | - |
| 2026-03-13 | Ms. Jill McConnellCFO | 2,48k | 0,00 | Derivative Exercise and Retained Stock | - | 72,28k | 3,55% |
| 2026-03-13 | Ms. Jill McConnellCFO | -1,80k | 16,63k | Derivative Exercise and Sale | 9,22 | 72,28k | - |
| 2026-03-09 | Mr. Robert ParksCAO | 3,34k | 0,00 | Derivative Exercise and Retained Stock | - | 22,39k | 17,55% |
| 2026-03-09 | Mr. Robert ParksCAO | -1,93k | 17,48k | Derivative Exercise and Sale | 8,93 - 9,21 | 22,39k | - |
| 2026-03-09 | Mr. Mark A. MoraisCOO & President of Clinical Services | 9,37k | 0,00 | Derivative Exercise and Retained Stock | - | 72,04k | 14,94% |
| 2026-03-09 | Mr. Mark A. MoraisCOO & President of Clinical Services | -4,60k | 41,71k | Derivative Exercise and Sale | 8,93 - 9,21 | 72,04k | - |
| 2026-03-09 | Ms. Jill McConnellCFO | 10,22k | 0,00 | Derivative Exercise and Retained Stock | - | 69,80k | 17,16% |
| 2026-03-09 | Ms. Jill McConnellCFO | -5,06k | 45,90k | Derivative Exercise and Sale | 8,93 - 9,21 | 69,80k | - |
| 2026-02-09 | Mr. Mark A. MoraisCOO & President of Clinical Services | 1,08k | 0,00 | Derivative Exercise and Retained Stock | - | 62,68k | 1,75% |
| 2026-02-09 | Mr. Mark A. MoraisCOO & President of Clinical Services | -1,18k | 16,36k | Derivative Exercise and Sale | 13,65 - 14,11 | 62,68k | - |
| 2026-02-09 | Ms. Jill McConnellCFO | 804,00 | 0,00 | Derivative Exercise and Retained Stock | - | 59,57k | 1,37% |
| 2026-02-09 | Ms. Jill McConnellCFO | -881,00 | 12,23k | Derivative Exercise and Sale | 13,65 - 14,11 | 59,57k | - |
| 2025-09-15 | Mr. Robert ParksCAO | 17,60k | 0,00 | Derivative Exercise and Retained Stock | - | 19,05k | 1.213,52% |
| 2025-09-15 | Mr. Robert ParksCAO | -7,34k | 73,01k | Derivative Exercise and Sale | 9,95 | 19,05k | - |
| 2025-09-08 | Mr. Robert ParksCAO | 1,45k | 0,00 | Derivative Exercise and Retained Stock | - | 1,45k | - |
| 2025-09-08 | Mr. Robert ParksCAO | -592,00 | 6,06k | Derivative Exercise and Sale | 10,23 | 1,45k | - |
| 2025-09-08 | Mr. James Stillman HansonInsider | 4,11k | 0,00 | Derivative Exercise and Retained Stock | - | 19,09k | 27,44% |
| 2025-09-08 | Mr. James Stillman HansonInsider | -1,68k | 17,16k | Derivative Exercise and Sale | 10,23 | 19,09k | - |
| 2025-09-08 | Mr. Mark A. MoraisCOO & President of Clinical Services | 4,00k | 0,00 | Derivative Exercise and Retained Stock | - | 61,60k | 6,95% |
| 2025-09-08 | Mr. Mark A. MoraisCOO & President of Clinical Services | -3,16k | 32,28k | Derivative Exercise and Sale | 10,23 | 61,60k | - |
| 2025-09-08 | Ms. Jill McConnellCFO | 4,00k | 0,00 | Derivative Exercise and Retained Stock | - | 58,77k | 7,30% |
| 2025-09-08 | Ms. Jill McConnellCFO | -3,16k | 32,29k | Derivative Exercise and Sale | 10,23 | 58,77k | - |
| 2025-09-02 | Ms. Erin L. RussellIndependent Director | 9,85k | 100,02k | Kauf | 10,15 | 9,85k | - |
| 2025-08-18 | Mr. Mark A. MoraisCOO & President of Clinical Services | 6,43k | 0,00 | Derivative Exercise and Retained Stock | - | 57,60k | 12,56% |
| 2025-08-18 | Mr. Mark A. MoraisCOO & President of Clinical Services | -4,89k | 39,14k | Derivative Exercise and Sale | 8,01 | 57,60k | - |
| 2025-08-18 | Ms. Jill McConnellCFO | 6,43k | 0,00 | Derivative Exercise and Retained Stock | - | 54,77k | 13,29% |
| 2025-08-18 | Ms. Jill McConnellCFO | -4,89k | 39,14k | Derivative Exercise and Sale | 8,01 | 54,77k | - |
| 2025-08-08 | Mr. Peter M. NeupertChairman of the Board & Lead Independent Director | 62,50k | 407,15k | Kauf | 6,26 - 6,79 | 98,13k | 175,40% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
